WOFIE Stimulates Regulatory T Cells: A 2-Year Follow-up of Renal Transplant Recipients1
Authors:
- Bettina DresskeBDBettina Dresske
- Frank HaendschkeFHFrank Haendschke
- Philine LenzPLPhiline Lenz
- Hendrik UngefrorenHUHendrik Ungefroren
- Stefan JenischSJStefan Jenisch
- Beate ExnerBEBeate Exner
- Nour Eddine El MokhtariNMNour Eddine El Mokhtari
- Tim LuTLTim Lu
- Nicholas ZavazavaNZNicholas Zavazava
- Fred FaendrichFFFred Faendrich
- 1 June 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 81 (11) , 1549-1557
Abstract
Initial interruption of immunosuppression for 72 hr was analyzed in renal transplant recipients according to Calne et al.'s "window of opportunity for immunologic engagement" (WOFIE) concept. This pilot study was designed as a randomized, open-label, prospective trial of 40 recipients (20 in the WOFIE group, 20 in the control group) of cadaveric kidney transplants who were followed up for 2 years. Immunosuppression comprised tacrolimus (trough levels 5-8 ng/mL), daclizumab (1 mg per kilogram of body weight on day 0 and after 2, 4, 6, and 8 weeks), mycophenolate mofetil (1-2 g/day), and prednisolone (maintenance dose of 10 mg/day). After induction with daclizumab, prednisolone, and mycophenolate mofetil, immunosuppression was interrupted for 72 hr in the WOFIE group. Steroid withdrawal followed in both groups within 12 to 16 weeks posttransplant. Patient and graft survival did not differ significantly between the two cohorts. However, the WOFIE group experienced less acute rejection episodes and developed better graft function. Although all but one of the patients in the WOFIE group successfully discontinued steroid treatment, permanent steroid withdrawal was achieved in only 76.4% of the control group. After daclizumab discontinuation, the WOFIE group demonstrated an increase of CD4CD25 T cells in peripheral blood (P<0.05 vs. control group), which was stable over time and strongly correlated with a significantly higher expression level of Foxp3-mRNA. Initial interruption of immunosuppression for 72 hr correlates with the induction of regulatory immunologic mechanisms and allows early and reliable minimization of immunosuppressive treatment.Keywords
This publication has 45 references indexed in Scilit:
- Effectiveness of Prophylactic Anti-HBV Therapy in Allogeneic Hematopoietic Stem Cell Transplantation with HBsAg Positive DonorsAmerican Journal of Transplantation, 2005
- WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation1Transplantation, 2003
- Strategies to Improve Long-Term Outcomes after Renal TransplantationNew England Journal of Medicine, 2002
- Steroid-free Immunosuppression in Kidney Transplantation: An Editorial ReviewAmerican Journal of Transplantation, 2002
- Cd4+Cd25+ Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory BlockadeJournal of Experimental Medicine, 2001
- Risk Factors for and Management of Post-Transplantation Cardiovascular DiseaseBioDrugs, 2001
- Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996New England Journal of Medicine, 2000
- CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1999
- WOFIE augments the immunosuppressive potency of FK-506Transplant Immunology, 1998
- TOLERANCE OF PORCINE RENAL ALLOGRAFTS INDUCED BY DONOR SPLEEN CELLS AND SEVEN DAYSʼ TREATMENT WITH CYCLOSPORINETransplantation, 1994